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Abstract 
Purpose: Practice-based research networks (PBRN) seek to shorten the gap between research and application in primary patient care 
settings. Inclusion of community pharmacies in primary care PBRNs is relatively unexplored.  Such a PBRN model could improve care 
coordination and community-based research, especially in rural and underserved areas.  The objectives of this study were to: 1) 
evaluate rural Appalachian community pharmacy key informants’ perceptions of PBRNs and practice-based research; 2) explore key 
informants’ perceptions of perceived applicability of practice-based research domains; and 3) explore pharmacy key informant 
interest in PBRN participation. 
Methods: The sample consisted of community pharmacies within city limits of all Appalachian Research Network (AppNET) PBRN 
communities in South Central Appalachia. A descriptive, cross-sectional, questionnaire-based study was conducted from November 
2013 to February 2014. Bivariate and multivariate analyses were conducted to examine associations between key informant and 
practice characteristics, and PBRN interest and perceptions.  
Findings: A 47.8% response rate was obtained. Most key informants (88%) were very or somewhat interested in participating in 
AppNET. Enrichment of patient care (82.8%), improved relationships with providers in the community (75.9%), and professional 
development opportunities (69.0%) were perceived by more than two-thirds of respondents to be very beneficial outcomes of PBRN 
participation.  Respondents ranked time constraints (63%) and workflow disruptions (20%) as the biggest barriers to PBRN 
participation.   
Conclusion: Key informants in rural Appalachian community pharmacies indicated interest in PBRN participation.  Integration of 
community pharmacies into existing rural PBRNs could advance community level care coordination and promote improved health 
outcomes in rural and underserved areas. 
 
 
Introduction 
The United States Department of Health and Human Services’ 
Agency for Healthcare Research and Quality (AHRQ) defines a 
practice-based research network (PBRN) as a “group of 
ambulatory practices devoted principally to the primary care 
of patients, and affiliated in their mission to investigate 
questions related to community-based practice and to  
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improve the quality of primary care”.1  PBRNs seek to shorten 
the gap between research and application and foster 
adoption of evidence-based findings in primary patient care 
settings.2 Importantly, evidence suggests when research is 
integrated within primary care practices, the practice 
constituents are more likely to incorporate research findings 
in to their day-to-day activities.3  PBRN participation engages 
health care professionals in practice-specific quality 
improvement efforts and is associated with multiple positive 
real and perceived practice outcomes, including, but not 
limited to, increased job satisfaction,4 practice 
improvements,5,6 and decreased intellectual isolation.7   
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The Appalachian Research Network (AppNET), a family 
medicine PBRN, was established in 2009 by the East 
Tennessee State University (ETSU) Department of Family 
Medicine.  Funding for AppNET was first provided by the 
Health Resources and Services Administration (HRSA) through 
a mechanism designed to grow PBRN resources in 
underserved areas (Grant # D54HP20673).  AppNET’s mission 
is to conduct and support practice-based research to improve 
the quality of rural primary care delivered in the region, and 
work toward the goal of eliminating health disparities in 
South Central Appalachia.  AppNET research efforts to date 
have focused in the areas of electronic health record clinic-
based quality improvement and prescription drug abuse-
related perceptions of clinicians; two topics that are 
applicable to and could be of interest to community 
pharmacists.    
 
AppNET is comprised of 17 family medicine clinics in 16 rural 
Northeast Tennessee, Southwest Virginia, and Western North 
Carolina communities. Several AppNET counties are 
designated as distressed or at risk by the Appalachian 
Regional Commission (ARC).8  This area of Appalachia has a 
higher rate of chronic disease and a higher proportion of 
individuals with disabilities compared to the nation as a 
whole and exceeds the national death rate for heart disease, 
cancer, stroke, diabetes, and chronic obstructive pulmonary 
disease.9  Moreover, the area is comprised of many rural 
counties with designated medically underserved 
areas/populations and primary care health professions 
shortage areas.8,10 
 
Pharmacists are accessible health care providers in many 
rural communities and are a logical cohort to engage in rural 
interprofessional research.  The role of community 
pharmacies in the delivery of health care in rural settings is 
well established.11-15  Rural pharmacists not only provide 
prescription dispensing services but also provide many non-
dispensing services such as immunizations, disease state 
management, medication therapy management (MTM), and 
services to local community health care organizations (e.g., 
long-term care facilities).16,17  Recent methodologically 
rigorous research highlights positive patient outcomes 
achieved through community pharmacist patient care 
activities.18-20  
 
An interprofessional team of health care providers and 
researchers within ETSU’s Academic Health Sciences Center 
seeks to expand AppNET into an interprofessional, rural PBRN 
that supports AppNET’s mission, facilitates rural, 
interprofessional practice-based research, and improves the 
care of patients in and around these communities.  Whereas 
pharmacists can and do participate in some types of 
interprofessional and interdisciplinary PBRNs (e.g., mixed 
PBRNs, family medicine PBRNs), a review of AHRQ PBRN 
descriptions reveals minimal incorporation of community 
pharmacists or pharmacies into PBRN activities.  Studies that 
evaluate community pharmacists’ perceptions of PBRNs or 
similar research networks have established wide variation in 
interest.  Carr and colleagues21 noted that over 83% of 
independent community pharmacists surveyed in Kentucky 
were interested or very interested in PBRN participation.  
Seel et al.22 found that 49.1% of surveyed community 
pharmacists in Indiana were somewhat or very interested in 
PBRN participation.  A 2011 study noted about 60% of 
community pharmacists in the Montreal, Quebec geographic 
area indicated interest in PBRN participation.23  Barriers to 
PBRN participation commonly mentioned by pharmacists in 
these studies included time constraints, lack of research 
experience, and a lack of funding to conduct research.21,22,24    
 
The objectives of this study were to: 1) evaluate rural 
Appalachian community pharmacy key informants’ 
perceptions of PBRNs and practice-based research; 2) explore 
key informants’ perceptions of perceived applicability of 
practice-based research domains; and 3) explore interest in 
AppNET participation among community pharmacy key 
informants.  
 
To our knowledge this is the first study that examines 
perceptions of feasibility and need for integration of 
community pharmacies, essential service providers in rural 
settings, into an interprofessional, rural PBRN.   
   
Methods 
Sample  
State-specific health professions licensing directories and web 
search tools were used to identify all pharmacies within the 
city limits of communities containing at least one AppNET-
affiliated clinic.  Two research assistants independently 
compiled community pharmacy information to ensure the 
sampling frame was complete. A total of 67 operational 
community pharmacies comprised the sampling frame.  
Researchers contacted each community pharmacy via 
telephone to describe the study and obtain contact 
information for one key informant at each pharmacy.  
 
Key informants were recruited in three waves across a 3-
month timeframe.  The first and second paper-based survey 
mailings were separated by 14 days.  Each mailing included a 
personalized cover letter, a brief description of PBRNs as 
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defined by AHRQ and a brief description of the AppNET PBRN. 
In addition to the survey instrument, the mailings also 
included a one-page frequently asked questions and answers 
document about PBRNs and a stamped return envelope. 
Approximately 90 days after the second paper-based mailing 
was sent, non-respondents received a follow-up phone call 
from the researchers to tailor the delivery mechanism (e.g., 
facsimile, email, mail) of the third request for study 
participation. A third request was made thereafter that was 
specific to contact preferences.  The follow-up phone call and 
subsequent survey instrument delivery were delayed in order 
to obtain an IRB modification to the study protocol and 
thereafter minimize non-response that might be associated 
with end-of-year holidays and beginning-of-year pharmacy 
volume.  No incentive was provided to key informants for 
study participation.   
 
Instrumentation 
Guided by previously published pharmacy-specific survey 
instruments,21,22 a 3-page, 50-item survey instrument was 
developed to capture information across five domains: 1) key 
informant and pharmacy demographic characteristics (e.g., 
age, gender, years licensed, weekly prescription volume); 2) 
service provision status within the key informant’s pharmacy 
(e.g., compounding, health screenings, immunizations, MTM); 
3) perceptions of research conduction in a community 
pharmacy; 4) benefits of and barriers to participation in a 
PBRN; and 5) overall interest in PBRN participation.  The 
survey instrument included items that elicited perceptions 
about interest in health information technology (HIT) and 
prescription drug abuse research; two topics of interest to 
PBRN researchers and clinicians. Five community pharmacists 
pilot tested survey instrument items for clarity and relevance.  
Minor wording changes and addition of research domains 
resulted from pilot testing.   Key informants responded to 
survey items using constructed response, categorical, and 5-
point Likert response scales. The survey instrument is 
provided in Appendix 1.   
 
Statistical Analysis  
All data were summarized in Microsoft Excel and imported 
into IBM SPSS version 20 for statistical analysis.  An a priori 
level of significance was set at α=0.05.  Descriptive statistics 
were examined for all items.  Fisher’s exact test was used to 
examine relationships between dichotomous key informant 
perceptions and practice setting type.  Mann-Whitney and 
Kruskal-Wallis tests were employed to examine differences in 
perceptions across gender and practice setting type, 
respectively.  Spearman correlations were used to examine 
relationships between perceived interest in PBRN 
participation and continuous demographic variables (age, 
number of prescriptions filled per week, number of full-time 
equivalent pharmacists and pharmacy technicians employed).  
Prior to instrument administration, IRB approval was granted 
by East Tennessee State University.  
 
Results 
Table 1 presents the characteristics of key informants and 
sample pharmacies.  Overall, 32 key informants returned the 
completed survey resulting in a 47.8% response rate.  A 
majority (78%) of independent pharmacy key informants 
were pharmacy owners whereas all chain and 
discount/supermarket pharmacy key informants were 
pharmacists in charge.  Respondents were mostly male (66%), 
had been licensed an average of 19.8 (±14.7) years, and were 
on average 44.8 (±13.7) years old.  Independent pharmacies 
were overrepresented in the analysis (60% of key informants 
vs. 45% of all AppNET pharmacies).  Respondents’ pharmacies 
employed, on average, 2.2 full-time equivalent (FTE) 
pharmacists and filled an average of 1623.8 (± 800.2) 
prescriptions per week. Almost all pharmacies provided MTM 
services (86.2%) and immunizations (80.0%)(Table 2).  Over 
half of pharmacies provided compounding (66.7%), health 
screenings (53.3%), and disease state management (51.7%) 
services.   
 
A majority of respondents were very (37.5%) or somewhat 
(50.0%) interested in participating in AppNET.  While interest 
did not vary significantly across a majority of key informant 
and pharmacy characteristics, there was a moderate negative 
correlation between number of full time pharmacists 
employed in a pharmacy and PBRN interest (r=-0.53; 
p=0.006).  Sixty-three percent and 20% of respondents 
ranked time constraints and workflow disruptions as the 
biggest barrier to PBRN participation, respectively (Figure 1).  
Differences in rankings were not statistically significantly 
different across key informant or pharmacy setting 
characteristics.   
 
Most respondents agreed or strongly agreed that 
participating in a research network would positively impact 
quality of patient care (82.7%), improve patient perceptions 
of the care they receive (75.8%), and improve employee 
perceptions of their work (75.8%) (Table 3). However, most 
key informants either responded neutrally (48.3%) or 
disagreed (24.1%) with the statement that they have enough 
knowledge about PBRNs to determine if participation in one 
is a good idea.  Statistically significant differences in 
perceptions of PBRN participation were not noted across key 
informant and practice setting characteristics.   
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When considering potential research topic applicability to 
their practice settings, over two-thirds of key informants 
indicated that medication therapy management (MTM) 
research (79.3%), medication adherence research (75.9%), 
reimbursement/third party research (72.4%), prescription 
drug abuse research (69.0%), and workflow related research 
(69.0%) were very applicable to their practices (Table 4).  
Independent pharmacy key informants indicated that health 
information technology research (p = 0.008) and 
reimbursement/third party research (p = 0.028) were more 
applicable to their settings as compared to key informants 
working in other pharmacy settings.  No other differences in 
research applicability were noted across respondent or 
practice setting characteristics. 
 
Enrichment of patient care (82.8%), improved relationships 
with providers in the community (75.9%), and professional 
development opportunities (69.0%) were perceived by more 
than two-thirds of respondents to be very beneficial 
outcomes of PBRN participation (Table 4).  Independent 
pharmacy respondents perceived an enhanced relationship 
with the study institution to be a more beneficial outcome as 
compared to respondents in other practice settings (p = 
0.041).  No other differences in perceived PBRN participation 
benefits were noted across respondent or practice setting 
characteristics. 
 
Discussion 
To our knowledge, this is the first study to explore feasibility 
of PBRN participation in rural community pharmacies and 
integration of community pharmacies into an already 
established rural PBRN.  Similar to the Carr et al. and Seel et 
al. studies, we found that most pharmacy key informants 
were somewhat or very interested in participating in a 
PBRN.21,22  However, we also noted that nearly three-fourths 
of respondents indicated they lacked sufficient knowledge 
about PBRNs to make an informed decision whether or not 
their pharmacy’s participation in a PBRN is a good idea.  This 
finding perhaps highlights the gap between research and 
practice and the complexity inherent in evaluating 
opportunity costs/gains associated with patient care and 
business/practice decisions.  Many respondents felt that 
PBRN participation would improve patient care and improve 
their professional relationships within the community.  
Considering obstacles faced by rural pharmacies, and 
independent pharmacies in particular, the dissonance in 
wanting to improve patient care and wanting to participate in 
the PBRN, but being cautious in decision-making is perhaps to 
be expected.13  Respondents indicated time constraints and 
workflow interruptions were the biggest barriers to PBRN 
participation.  Whereas time commitment and workflow 
disruption could be considered project dependent, research 
is warranted to quantify the return on investment, or lack 
thereof, associated with PBRN participation, including 
intangible factors that are difficult to assess (e.g., patient care 
enrichment, pharmacy-prescriber relationships).  Overall, 
increased information about PBRNs and the potential costs 
and benefits resulting from participation from the community 
pharmacy perspective are needed based on key informant 
responses.   
 
Carr et al noted that over 95% of surveyed pharmacists 
perceived compensation to be necessary for PBRN 
participation.21  Exploration of financial incentives necessary 
for participating in AppNET was not examined directly in our 
study, but nearly two-thirds of respondents indicated 
increased revenue as a very beneficial aspect of PBRN 
participation.  Considering that a large percentage of 
respondents represented rural independent pharmacies, 
particular attention should be given to beneficial financial 
outcomes of PBRN participation, including potential revenue 
increases (e.g., revenues associated with implementation of 
study-supported services, increases in prescription volume 
associated with medication adherence projects) and financial 
incentives for participation.    
 
More than 90% of key informants indicated all proposed 
research domains were somewhat or very applicable to their 
practices.  Importantly, several of the domains included in the 
survey instrument were directly applicable to improving 
health outcomes in the region.  For example, medication 
adherence research and improvement could positively impact 
multiple disease states, including cardiovascular disease, 
diabetes, chronic obstructive pulmonary disease, and other 
ambulatory care sensitive conditions that are prevalent in 
rural Appalachia and likely managed by primary care 
providers within AppNET communities.25  Whereas formal 
integration of community pharmacies into AppNET has yet to 
be realized, focus group studies specific to interprofessional 
prescription drug abuse communication have 
successfully been conducted with AppNET prescribers and 
pharmacists.  
 
Consistent with previous literature on health services 
provided by rural community pharmacies, pharmacies 
represented by key informants provided multiple services 
that have been shown to improve health care delivery within 
their communities.  Conducting research on those services 
offered by a majority of community pharmacies (e.g., MTM, 
health screenings) could perhaps facilitate transition into 
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practice-based research with minimal impact on time 
constraints and workflow concerns.  Likewise, research on 
services being considered by community pharmacies could 
also promote the utility of practice-based research, facilitate 
PBRN participation, and inform decision-making regarding 
service provision.  
 
Whereas PBRNs have historically placed emphasis on 
research engagement, some PBRNs have integrated an 
additional “R” into the PBRN acronym by providing resources 
to participating practices.  For example, the Oklahoma 
Physicians Resource/Research Network (OKPRN) mentions 
peer learning and shared resources in its mission statement.26  
As pharmacies are recruited to AppNET membership, the 
potential resources that PBRN staff, including practice 
enhancement assistants, could provide to members should 
also be considered.  Research domains of interest to key 
informants, in particular, could guide resource development.  
Our interprofessional research specific to prescription drug 
abuse within AppNET communities supports the need for 
resource development and dissemination.  To our knowledge, 
current pharmacy-specific PBRNs do not emphasize resource 
provision to their members.   
 
Recruitment of community pharmacies into AppNET will 
create a unique, interprofessional PBRN.  The rural, 
underserved environment in which study pharmacies are 
located, geographic distance between communities, and 
geographic distance of pharmacies from the research 
institution will create challenges in integrating community 
pharmacies into AppNET.  Yet, AppNET expansion, and 
integration of community pharmacies in to primary care 
PBRNs generally, presents an opportunity to conduct 
multifaceted, interdisciplinary research to solve community-
specific health problems and promote evidence-based 
interprofessional patient care.  Rural and underserved 
communities could realize increased return on investment 
through resource sharing and interprofessional, community-
based research collaboration associated with PBRN 
participation.  Further research is warranted to develop PBRN 
enrollment mechanisms that minimize barriers to 
participation of community pharmacies in practice-based 
research. 
 
Limitations 
There are several limitations to our study that deserve 
mention.  First, after employing three recruitment waves, 
including one telephone call to community pharmacies, a 
response rate of 47.8% was obtained.  It is hypothesized that 
non-responders would be more likely to be uninterested in 
PBRN participation as compared to respondents.  However, 
non-response bias analyses indicated no statistically 
significant differences in PBRN interest between key 
informants who responded to the first wave and those who 
responded to subsequent contact attempts.  Overall, a larger 
percentage of independent pharmacy key informants 
participated in the study as compared to key informants in 
non-independently owned pharmacies (60% vs. 38%).  
However, no differences were noted in practice setting 
characteristics across early and late responders. Our small 
sample size also limits statistical power to detect a difference 
where differences in perceptions indeed exist.  The extent to 
which the key informant who responded to the survey has 
the ability to make the decision to participate in AppNET is 
unknown. In particular, respondents who are employed in 
non-independently owned pharmacies may have limited 
influence on participation.  Finally, the potential for social 
desirability bias should be considered as the respondents 
were aware the team administering the survey instrument 
was research-focused.    
 
Conclusion  
A large majority of key informants in rural Appalachian 
community pharmacies indicated interest in participating in 
an established primary care PBRN.  Respondents noted 
several positive perceptions of PBRN participation, including 
improved quality of patient care, and improved employee 
perceptions of their work.  Multiple research domains were 
of interest, including projects currently being conducted with 
AppNET prescribers, and multiple perceived benefits of PBRN 
participation were noted. The interest in AppNET expressed 
by community pharmacists is an exciting first step towards 
integrating this cohort into the PBRN.  Ultimately, the 
development of PBRNs that include and employ community 
pharmacies could positively advance community level care 
coordination and promote improved health outcomes in rural 
and underserved areas.   
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Table 1.  Pharmacy key informant demographic and practice setting characteristics (N=32).a 
Variable Numeric Value 
Gender, No. (%)   
          Female 11 (34.4) 
          Male 21 (65.6) 
Setting, No. (%)  
          Chain 10 (31.3) 
          Independent 18 (56.3) 
          Supermarket/discount store 4 (12.5) 
Respondent position/title  
Owner 14 (43.8) 
Pharmacist in charge 15 (46.9) 
Staff pharmacist 1 (3.1) 
Other 2 (6.3) 
Age, Mean (SD) 44.8 (13.7) 
Years licensed as pharmacist, Mean (SD) 19.8 (14.7) 
Years affiliated with current pharmacy, Mean (SD) 16.7 (13.9) 
Prescriptions filled per week, Mean (SD) 1623.8 (800.2) 
Pharmacist full time equivalents in setting, Mean (SD) 2.2 (0.9) 
Technician full time equivalents in setting, Mean (SD) 3.6 (1.8) 
Pharmacy students precepted annually in setting, Mean (SD) 2.9 (5.1) 
a: Totals do not always add to 32 due to missing data 
 
 
 
 
 
Table 2.  Pharmacy patient care service characteristics (N = 30).a 
 Response, No. (%) 
Service Provide Do Not Provide Considering Providing 
Medication Therapy Management (MTM) 25 (86.2) 3 (10.3) 1 (3.4) 
Immunizations 24 (80.0) 3 (10.0) 3 (10.0) 
Compounding 20 (66.7) 9 (30.0) 1 (3.3) 
Health Screenings 16 (53.3) 8 (26.7) 6 (20.0) 
Disease State Management 15 (51.7) 10 (34.5) 4 (13.8) 
Delivery 12 (40.0) 13 (43.3) 5 (16.7) 
Tailored Medication Packaging 10 (33.3) 16 (53.3) 4 (13.3) 
Durable Medical Equipment (DME) 9 (30.0) 18 (60.0) 3 (10.0) 
a: Totals do not always add to 30 due to missing data 
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Table 3. Pharmacists’ perceptions of participating in a practice-based research network (PBRN) (N=29). 
 Responses, No. (%)  
Item Strongly Disagree Disagree Neutral Agree 
Strongly 
Agree 
Research can be conducted in the community 
pharmacy setting 
 
0 (0) 2 (7.1)  2 (7.1) 14 (50.0) 10 (35.7) 
Participation in a research network could 
positively impact the quality of care my patients 
receive 
 
0 (0) 1 (3.4) 4 (13.8) 17 (58.6) 7 (24.1) 
Participation in a research network could 
improve my patients’ perceptions of the care 
they receive 
 
0 (0) 0 (0) 7 (24.1) 13 (44.8) 9 (31.0) 
Participation in a research network could 
positively impact my employees’ perceptions of 
their work 
 
0 (0) 1 (3.4) 6 (20.7) 13 (44.8) 9 (31.0) 
Participation in a research network could inform 
the business decisions I make in my pharmacy 
 
0 (0) 1 (3.4) 10 (34.5) 14 (48.3) 4 (13.8) 
I know enough about PBRNs to make an 
informed decision whether or not my pharmacy’s 
participation in a PBRN is a good idea 
2 (6.9)  5 (17.2) 14 (48.3) 7 (24.1) 1 (3.4) 
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Table 4.  Perceived applicability of research domains and perceived benefit of potential PBRN participation outcomes (N=29). 
 Response, No. (%) 
Research domain Not at all applicable Somewhat applicable Very applicable 
Medication therapy management 1 (3.4) 5 (17.2) 23 (79.3) 
Medication adherence 0 (0) 7 (24.1) 22 (75.9) 
Reimbursement/third party 0 (0) 8 (27.6) 21 (72.4) 
Prescription drug abuse 0 (0) 9 (31.0) 20 (69.0) 
Workflow 0 (0) 9 (31.0) 20 (69.0) 
Patient satisfaction 0 (0) 10 (34.5) 19 (65.5) 
Medication safety 0 (0) 15 (51.7) 14 (48.3) 
Value-added services 1 (3.4) 13 (44.8) 15 (46.9) 
Health information technology  2 (6.9) 15 (51.7) 12 (41.4) 
 Response, No. (%) 
Perceived benefit domain Not at all beneficial Somewhat beneficial Very beneficial 
Enrichment of patient care 0 (0) 5 (17.2) 24 (82.8) 
Improved relationships with providers in the community 0 (0) 7 (24.1) 22 (75.9) 
Professional development opportunities 1 (3.4) 8 (27.6) 20 (69.0) 
Enhancement of the pharmacy “image” 0 (0) 10 (34.5) 19 (65.5) 
Increased revenue 2 (6.9) 9 (31.0) 18 (62.1) 
Access to pharmacy-specific data and reports 0 (0) 13 (44.8) 16 (55.2) 
Enhanced relationship with ETSUa 1 (3.4) 14 (48.3) 14 (48.3) 
a: ETSU = East Tennessee State University 
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Figure 1.  Key informant rankings of barriers to practice-based research network participation (1 = biggest barrier; 5 = 
smallest barrier).  
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SECTION	  1:	  PHARMACIST	  INFORMATION	  
For	  how	  many	  years	  have	  you	  been	  affiliated	  with	  this	  pharmacy?	  
	  	  	  	  	  	  ____________	  year(s)	  
For	  how	  many	  years	  have	  you	  been	  a	  licensed	  pharmacist?	  
	  	  	  	  	  	  ____________	  year(s)	  
What	  is	  your	  age?	  
	  	  	  	  	  	  ____________	  years	  
Which	  of	  the	  following	  best	  describes	  your	  position	  or	  title?	  
¨	  Staff	  pharmacist	  
¨	  Pharmacist-­‐in-­‐charge	  (PIC)	  
¨	  Owner	  
¨	  Other	  (please	  specify)	  _____________________________________________________	  
Please	  indicate	  your	  gender:	  	  	  	  	  	  	  	  	  	  	  	  
¨	  Female	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Male	  
SECTION	  2:	  PHARMACY	  INFORMATION	  
What	  is	  the	  name	  of	  your	  pharmacy?	  	  	  
__________________________________________________________	  
In	  what	  town/city	  is	  your	  pharmacy	  located?	  	  	  
__________________________________________________________	  
Please	  indicate	  whether	  your	  pharmacy	  currently	  provides,	  does	  not	  provide,	  or	  is	  considering	  providing	  each	  
of	  the	  following	  patient	  care	  services:	  	  
− Compounding	  
	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Provide	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Do	  Not	  Provide	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Considering	  Providing	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
− Delivery	  
	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Provide	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Do	  Not	  Provide	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Considering	  Providing	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
− Disease	  State	  Management	  
	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Provide	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Do	  Not	  Provide	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Considering	  Providing	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
− Durable	  Medical	  Equipment	  (DME)	  
¨	  Provide	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Do	  Not	  Provide	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Considering	  Providing	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
− Health	  Screenings	  
¨	  Provide	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Do	  Not	  Provide	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Considering	  Providing	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
− Immunizations	  
¨	  Provide	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Do	  Not	  Provide	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Considering	  Providing	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
− Medication	  Therapy	  Management	  (MTM)	  
¨	  Provide	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Do	  Not	  Provide	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Considering	  Providing	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
− Tailored	  Medication	  Packaging	  
¨	  Provide	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Do	  Not	  Provide	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Considering	  Providing	  	  
On	  average,	  how	  many	  prescriptions	  does	  your	  pharmacy	  fill	  per	  week?	  
	  	  	  	  	  	  _____________	  prescriptions	  per	  week	  
How	  many	  full-­‐time	  equivalent	  (FTE)	  pharmacists	  does	  your	  pharmacy	  employ?	  
	  	  	  	  	  _____________	  FTEs	  for	  pharmacists	  
How	  many	  full-­‐time	  equivalent	  (FTE)	  certified	  pharmacy	  technicians	  does	  your	  pharmacy	  employ?	  
	  	  	  	  	  _____________	  FTEs	  for	  certified	  technicians	  
On	  average,	  how	  many	  pharmacy	  students	  does	  your	  pharmacy	  precept	  annually?	  
	  	  	  	  	  _____________	  students	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (Please	  continue	  to	  next	  page)	  
	  	  
SECTION	  3:	  PERCEPTIONS	  OF	  COMMUNITY	  PHARMACY	  AND	  RESEARCH	  
On	  a	  scale	  of	  1	  (strongly	  disagree)	  to	  5	  (strongly	  agree),	  please	  indicate	  the	  extent	  to	  which	  you	  disagree/	  
agree	  with	  each	  of	  the	  following	  statements.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   	   	  	  	  	  2	   	   	  	  	  	  	  3	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  4	   	   	  	  	  	  	  	  	  	  	  5	  
	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Strongly	  	  	  	  	  	  	  	  	  	  	  	  Disagree	  	  	  	  	  	  	  	  	  	  	  	  	  	  Neutral	   	  	  	  	  Agree	   	  	  	  	  Strongly	  	  
	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Disagree	  	   	   	   	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Agree	  
	  
Please	  circle	  one	  number	  for	  each	  item	   SD	  	  	  	  	  D	  	  	  	  	  	  	  	  N	  	  	  	  	  	  	  A	  	  	  	  	  	  SA	  
Research	  can	  be	  conducted	  in	  the	  community	  pharmacy	  setting	   1	  	  	  	  	  	  	  2	  	  	  	  	  	  	  	  3	  	  	  	  	  	  	  	  4	  	  	  	  	  	  	  	  5	  
Participation	  in	  a	  research	  network	  could	  positively	  impact	  the	  quality	  of	  care	  my	  
patients	  receive	  
1	  	  	  	  	  	  	  2	  	  	  	  	  	  	  	  3	  	  	  	  	  	  	  	  4	  	  	  	  	  	  	  	  5	  
Participation	  in	  a	  research	  network	  could	  improve	  my	  patients’	  perceptions	  of	  
the	  care	  they	  receive	  
1	  	  	  	  	  	  	  2	  	  	  	  	  	  	  	  3	  	  	  	  	  	  	  	  4	  	  	  	  	  	  	  	  5	  
Participation	  in	  a	  research	  network	  could	  positively	  impact	  my	  employees’	  
perceptions	  of	  their	  work	  	  
1	  	  	  	  	  	  	  2	  	  	  	  	  	  	  	  3	  	  	  	  	  	  	  	  4	  	  	  	  	  	  	  	  5	  
Participation	  in	  a	  research	  network	  could	  inform	  the	  business	  decisions	  I	  make	  in	  
my	  pharmacy	  
1	  	  	  	  	  	  	  2	  	  	  	  	  	  	  	  3	  	  	  	  	  	  	  	  4	  	  	  	  	  	  	  	  5	  
I	  know	  enough	  about	  PBRNs	  to	  make	  an	  informed	  decision	  whether	  or	  not	  my	  
pharmacy’s	  participation	  in	  a	  PBRN	  is	  a	  good	  idea	  
1	  	  	  	  	  	  	  2	  	  	  	  	  	  	  	  3	  	  	  	  	  	  	  	  4	  	  	  	  	  	  	  	  5	  
SECTION	  4:	  PBRN	  PARTICIPATION	  
Listed	  below	  are	  5	  potential	  barriers	  to	  participation	  in	  a	  PBRN.	  	  Using	  each	  number	  only	  once,	  please	  rank	  
order	  the	  factors	  from	  1	  (biggest	  barrier)	  to	  5	  (smallest	  barrier)	  as	  you	  perceive	  them	  in	  your	  practice	  setting.	  
	  
_______	  Time	  constraints	  
_______	  Lack	  of	  direct	  financial	  incentives	  
_______	  Lack	  of	  personal	  experience	  doing	  research	  
_______	  Lack	  of	  employer	  support	  to	  participate	  in	  research	  
_______	  Potential	  interruption	  of	  pharmacy	  workflow	  
	  
Please	  indicate	  the	  extent	  to	  which	  you	  think	  each	  of	  the	  following	  PBRN	  research	  topics	  is	  applicable	  to	  
your	  community	  pharmacy	  practice	  setting.	  	  	  
− Health	  information	  technology	  research	  
¨	  Not	  at	  all	  applicable	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Somewhat	  applicable	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Very	  applicable	  
− Medication	  adherence	  research	  
¨	  Not	  at	  all	  applicable	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Somewhat	  applicable	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Very	  applicable	  
− Medication	  safety	  research	  
¨	  Not	  at	  all	  applicable	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Somewhat	  applicable	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Very	  applicable	  
− Medication	  therapy	  management	  (MTM)	  research	  
¨	  Not	  at	  all	  applicable	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Somewhat	  applicable	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Very	  applicable	  
− Patient	  satisfaction	  research	  
¨	  Not	  at	  all	  applicable	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Somewhat	  applicable	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Very	  applicable	  
− Prescription	  drug	  abuse	  research	  
¨	  Not	  at	  all	  applicable	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Somewhat	  applicable	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Very	  applicable	  
− Reimbursement/third	  party-­‐related	  research	  
¨	  Not	  at	  all	  applicable	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Somewhat	  applicable	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Very	  applicable	  
(Please	  continue	  to	  next	  page)	  
	  	  
Please	  indicate	  the	  extent	  to	  which	  you	  think	  each	  of	  the	  following	  PBRN	  research	  topics	  is	  applicable	  to	  
your	  community	  pharmacy	  practice	  setting.	  	  	  
− Value-­‐added	  services	  research	  
¨	  Not	  at	  all	  applicable	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Somewhat	  applicable	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Very	  applicable	  
− Workflow-­‐related	  research	  
¨	  Not	  at	  all	  applicable	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Somewhat	  applicable	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Very	  applicable	  
− Other	  (please	  specify)	  ________________________________________	  
¨	  Not	  at	  all	  applicable	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Somewhat	  applicable	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Very	  applicable	  
Please	  indicate	  the	  extent	  to	  which	  you	  perceive	  each	  of	  the	  following	  outcomes	  of	  PBRN	  participation	  to	  be	  
beneficial	  to	  your	  pharmacy.	  	  
− Access	  to	  pharmacy-­‐specific	  data	  and	  reports	  
¨	  Not	  at	  all	  beneficial	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Somewhat	  beneficial	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Very	  beneficial	  
− Enhanced	  relationship	  with	  East	  Tennessee	  State	  University	  
¨	  Not	  at	  all	  beneficial	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Somewhat	  beneficial	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Very	  beneficial	  
− Enhancement	  of	  the	  pharmacy	  “image”	  
¨	  Not	  at	  all	  beneficial	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Somewhat	  beneficial	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Very	  beneficial	  
− Enrichment	  of	  patient	  care	  
¨	  Not	  at	  all	  beneficial	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Somewhat	  beneficial	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Very	  beneficial	  
− Improved	  relationships	  with	  providers	  in	  the	  community	  
¨	  Not	  at	  all	  beneficial	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Somewhat	  beneficial	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Very	  beneficial	  
− Increased	  revenue	  
¨	  Not	  at	  all	  beneficial	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Somewhat	  beneficial	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Very	  beneficial	  
− Professional	  development	  opportunities	  
¨	  Not	  at	  all	  beneficial	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Somewhat	  beneficial	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Very	  beneficial	  
− Other	  (please	  specify)	  _______________________________________	  
¨	  Not	  at	  all	  beneficial	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Somewhat	  beneficial	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Very	  beneficial	  
Based	  on	  the	  information	  provided,	  how	  would	  you	  describe	  your	  interest	  in	  participating	  in	  the	  AppNET	  PBRN	  
with	  providers	  and	  other	  pharmacies	  in	  your	  area?	  
¨	  I	  am	  very	  interested	  
¨	  I	  am	  somewhat	  interested	  
¨	  I	  am	  not	  interested	  	  
What	  additional	  information	  would	  you	  like	  to	  know	  about	  the	  AppNET	  PBRN?	  
_________________________________________________________________________________________	  
_________________________________________________________________________________________	  
_________________________________________________________________________________________	  
If	  your	  pharmacy	  is	  interested	  in	  participating	  in	  the	  PBRN	  or	  has	  questions	  about	  participation,	  please	  provide	  
the	  name	  and	  contact	  information	  for	  the	  primary	  contact	  person	  at	  your	  pharmacy	  to	  whom	  future	  
communication	  should	  be	  directed.	  
Name:	  ___________________________________________________	  
Email:	  ___________________________________________________	  	  	  	  	  
Telephone	  number:	  ________________________________________	  
Preferred	  contact	  method:	  	  	  	  	  ¨	  Email	  	  	  	  ¨	  Telephone	  
Thank	  you	  for	  your	  thoughts!	  
	  
